Medico Remedies Ltd (MEDICO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002925, "name": "Medico Remedies", "stock_name": "Medico Remedies", "full_name": "Medico Remedies Ltd", "name_url": "stocks-analysis/medico-remedies", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "26.14", "chg": -6.53, "chgp": "-19.99%", "dir": -1, "prev_price": "32.67", "mcapval": "271.00 Cr", "mcap": "Micro Cap", "scripcode": 540937, "symbol": "MEDICO", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE630Y01024", "curr_date": "Sep 25, 03:30 PM", "curr_time": "21:26 PM", "last_traded_at": "Sep 25, 03:30 PM IST", "bse_nse_vol": "38.59 lacs", "exc_status": "Active", "traded_date": "Sep 25, 2026", "traded_date_str": "2026 09 25", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medico-remedies-1002925-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Medico Remedies Ltd Locks at Lower Circuit With 20.0% Loss — Sellers Queue, No Buyers in Sight", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-ltd-plunges-20-to-hit-lower-circuit-amid-heavy-selling-pressure-4205113", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/MedicoRemediesL_stocks_hitting_lower_circuit_4205113.png", "date": "2026-09-25 12:00:10", "description": "At Rs 26.00, sellers were still queuing — but there were no buyers willing to take the other side. Medico Remedies Ltd locked at its lower circuit of 20.0% on 25 Sep 2026, with unfilled sell orders and a frozen price." }, { "title": "Medico Remedies Ltd Falls to 52-Week Low of Rs 29.86 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-ltd-falls-to-52-week-low-of-rs2986-amid-continued-downtrend-4204991", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/MedicoRemediesL_priceRelatedfactors_4204991.png", "date": "2026-09-25 10:38:24", "description": "For the sixth consecutive session, Medico Remedies Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 29.86 on 25 Sep 2026. This extended sell-off has dragged the stock down by nearly 16% over this period, significantly underperforming its sector and broader market indices." }, { "title": "Medico Remedies Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-sell-4202263", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/MedicoRemediesL_mojoScore_4202263.png", "date": "2026-09-23 10:11:11", "description": "Medico Remedies Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 September 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 September 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Medico Remedies Ltd Downgraded as Quality Parameters Show Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-ltd-downgraded-as-quality-parameters-show-mixed-signals-4193839", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/MedicoRemediesL_qualitydot_4193839.png", "date": "2026-09-16 08:00:06", "description": "Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its quality grade downgraded from good to average as of 15 Sep 2026. This shift reflects a nuanced change in the company’s underlying business fundamentals, including key metrics such as return on equity (ROE), return on capital employed (ROCE), debt levels, and growth consistency. The downgrade accompanies a revised Mojo Score of 43.0 and a Sell rating, marking a significant change from its previous Hold status." }, { "title": "Medico Remedies Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-hold-by-marketsmojo-4190287", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/MedicoRemediesL_mojoScore_4190287.png", "date": "2026-09-11 10:11:08", "description": "Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 26 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 September 2026, providing investors with the latest insights into the company's performance and outlook." }, { "title": "Medico Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-ltd-valuation-shifts-signal-renewed-price-attractiveness-4175302", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/MedicoRemediesL_valuationdot_4175302.png", "date": "2026-08-31 08:00:58", "description": "Medico Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling a potential investment opportunity in the Pharmaceuticals & Biotechnology micro-cap segment. This change comes amid a challenging market backdrop and relative valuation pressures from its peers, prompting a reassessment of its price-to-earnings and price-to-book value multiples." }, { "title": "Medico Remedies Ltd Edges Down 0.19%: 2 Key Valuation and Rating Shifts This Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-ltd-edges-down-019-2-key-valuation-and-rating-shifts-this-week-4174317", "imagepath": "", "date": "2026-08-29 13:01:07", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>24 Aug:</strong> Stock opens at ₹41.67, down 1.84% amid sector challenges</p>\n <p><strong>25 Aug:</strong> Valuation upgrade signals renewed price attractiveness</p>\n <p><strong>27 Aug:</strong> Mojo Grade upgraded to Hold on improved financial trends</p>\n <p><strong>28 Aug:</strong> Week closes at ₹42.37, down 0.19% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.42.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value..." }, { "title": "Medico Remedies Ltd Upgraded to Hold on Improved Valuation and Financial Trends", "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-upgraded-to-hold-on-improved-valuation-and-financial-trends-4171046", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/MedicoRemediesL_mojoScore_4171046.png", "date": "2026-08-27 08:26:59", "description": "Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 26 August 2026. This shift reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. While the company demonstrates improving fundamentals and attractive valuation metrics, technical indicators remain mixed, warranting a cautious stance for investors." }, { "title": "Medico Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-sector-challenges-4168251", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/MedicoRemediesL_valuationdot_4168251.png", "date": "2026-08-25 08:01:54", "description": "Medico Remedies Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating despite ongoing sector headwinds. With a current price of ₹41.67 and a micro-cap market classification, the pharmaceutical company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a more compelling investment case relative to its historical averages and peer group." } ], "total": 206, "sid": "1002925", "stock_news_url": "https://www.marketsmojo.com/news/medico-remedies-1002925" }, "announcements": [ { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "23-Sep-2026", "details": "Please find enclosed Voting Results and Scrutinizer Report for AGM", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM", "datetime": "22-Sep-2026", "details": "Please Find Enclosed Proceedings of 32nd AGM", "source": "BSE" }, { "caption": "Reg. 34 (1) Annual Report.", "datetime": "29-Aug-2026", "details": "Please find enclosed.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Medico Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 16 Mar 23", "dt": "2023-03-16", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Medico Remedies Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 16 Nov 21", "dt": "2021-11-16", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

24 Aug: Stock opens at ₹41.67, down 1.84% amid sector challenges

25 Aug: Valuation upgrade signals renewed price attractiveness

27 Aug: Mojo Grade upgraded to Hold on improved financial trends

28 Aug: Week closes at ₹42.37, down 0.19% for the week

Week Open

Rs.42.45

Week Close

Read full news article

Medico Remedies Ltd Upgraded to Hold on Improved Valuation and Financial Trends

2026-08-27 08:26:59

Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 26 August 2026. This shift reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. While the company demonstrates improving fundamentals and attractive valuation metrics, technical indicators remain mixed, warranting a cautious stance for investors.

Read full news article

Medico Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges

2026-08-25 08:01:54

Medico Remedies Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating despite ongoing sector headwinds. With a current price of ₹41.67 and a micro-cap market classification, the pharmaceutical company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a more compelling investment case relative to its historical averages and peer group.

Read full news article